Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 26, 2025
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tatva Chintan Pharma Chem held its 29th AGM on September 26, 2025 via video conferencing, lasting about 36 minutes. All 7 directors and key managerial personnel were present, and 50 members attended. Twelve resolutions were put to e-vote, including adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, declaration of a dividend on equity shares, and the re-appointment of the Managing Director, two Whole-time Directors, and three Independent Directors. The Chairman (Mr. Chintan Shah) and the Investor Relations Officer also presented financial highlights for FY25. The Company Secretary confirmed that voting was conducted entirely through remote e-voting and e-voting at the AGM, with results to be declared separately by the scrutinizer (M/s. TNT & Associates) and disseminated to the exchanges in due course.
For shareholders, the key items to watch are the dividend declaration (subject to e-vote approval) and the re-appointment of the leadership team, which signals management continuity. Voting results, once announced, may influence short-term stock movement, particularly if the dividend per share differs from market expectations.